GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently gaining a prominent focus in medical studies, largely due to its remarkable impact on controlling conditions such as second type diabetes and weight gain. New trials have demonstrated that more than glucose management, GLP-1